NCT06541262 2026-03-02Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsMilton S. Hershey Medical CenterPhase 1/2 Recruiting104 enrolled
NCT06709495 2026-02-19Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory SarcomasDana-Farber Cancer InstitutePhase 1/2 Recruiting63 enrolled